Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R KAYSER

Showing results (11-20 of 110) with videos related to

Pageof 11
Sort By:
Progress in Cardiovascular Nursing|January 1, 1996
Management of venous thromboembolic (VTE) disease--Part II: TreatmentS R Kayser
Progress in Cardiovascular Nursing|January 1, 1994
New drugs 1994: trapidil, torsemideS R Kayser
Progress in Cardiovascular Nursing|January 1, 1996
Antiarrhythmic drug therapy--Part II: Specific drugsS R Kayser
Progress in Cardiovascular Nursing|June 6, 1998
Low-molecular-weight heparins in the management of cardiovascular conditionsS R Kayser
Progress in Cardiovascular Nursing|January 1, 1997
Ibutilide--a new drug for the rapid termination of atrial fibrillation and atrial flutterS R Kayser
Progress in Cardiovascular Nursing|January 1, 1996
Antiarrhythmic drug therapy--Part I: General principles of drug selectionS R Kayser
Progress in Cardiovascular Nursing|January 5, 2008
The use of nesiritide in the management of acute decompensated heart failure. 2002Steven R Kayser
Progress in Cardiovascular Nursing|February 9, 1999
Use of epoprostenol (Flolan) in the management of primary pulmonary hypertensionS R Kayser
Progress in Cardiovascular Nursing|June 2, 2007
Pharmacogenomics and the potential for personalized therapeutics in cardiovascular diseaseSteven R Kayser
Progress in Cardiovascular Nursing|January 1, 1996
Antiarrhythmic drug therapy--part III: atrial fibrillationS R Kayser
Pageof 11

Showing results (11-20 of 110) with videos related to

Sort By:
Pageof 11
Progress in Cardiovascular Nursing|January 1, 1996
Management of venous thromboembolic (VTE) disease--Part II: TreatmentS R Kayser
Progress in Cardiovascular Nursing|January 1, 1994
New drugs 1994: trapidil, torsemideS R Kayser
Progress in Cardiovascular Nursing|January 1, 1996
Antiarrhythmic drug therapy--Part II: Specific drugsS R Kayser
Progress in Cardiovascular Nursing|June 6, 1998
Low-molecular-weight heparins in the management of cardiovascular conditionsS R Kayser
Progress in Cardiovascular Nursing|January 1, 1997
Ibutilide--a new drug for the rapid termination of atrial fibrillation and atrial flutterS R Kayser
Progress in Cardiovascular Nursing|January 1, 1996
Antiarrhythmic drug therapy--Part I: General principles of drug selectionS R Kayser
Progress in Cardiovascular Nursing|January 5, 2008
The use of nesiritide in the management of acute decompensated heart failure. 2002Steven R Kayser
Progress in Cardiovascular Nursing|February 9, 1999
Use of epoprostenol (Flolan) in the management of primary pulmonary hypertensionS R Kayser
Progress in Cardiovascular Nursing|June 2, 2007
Pharmacogenomics and the potential for personalized therapeutics in cardiovascular diseaseSteven R Kayser
Progress in Cardiovascular Nursing|January 1, 1996
Antiarrhythmic drug therapy--part III: atrial fibrillationS R Kayser
Pageof 11